Literature DB >> 12226833

Measles virus strains circulating in Central and West Africa: Geographical distribution of two B3 genotypes.

D Waku Kouomou1, E Nerrienet, J Mfoupouendoun, G Tene, H Whittle, T F Wild.   

Abstract

Africa remains one of the major reservoirs of measles infection. Molecular epidemiological studies have permitted different measles virus isolates to be grouped into clades and genotypes; the major group, which has been identified as indigenous to Africa, is clade B. The viruses from epidemics in the Gambia (1993) and in the Cameroon (2001) were examined. In both studies, the homogeneity of the virus isolates within the epidemic as shown by sequence analysis revealed less than 0.2% variation of nucleotides between isolates. The measles viruses isolated in 1983 in Yaoundé, Cameroon, were designated as the B1 genotype. However, in 2001 only viruses belonging to the B3 genotype were found in this city. The viruses in the Gambia (1993) were also of the B3 genotype. However, these viruses could be distinguished from each other at the antigenic level and by comparative sequence analysis. The B3 Cameroon (2001) viruses were related to the proposed B3.1 subgroup, whereas the Gambian (1993) isolates corresponded to the B3.2 subgroup. The geographical distribution for the period 1993-2001 of these two viruses shows that B3.1 is found from the Sudan to Nigeria and Ghana extending south to the Cameroon, whereas the B3.2 genotype is found in West Africa. In Nigeria and Ghana, the viruses co-circulate. The identification of these viruses will permit more meaningful epidemiological studies after the proposed increase in measles vaccination coverage. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226833     DOI: 10.1002/jmv.10222

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

Review 1.  Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras.

Authors:  Michaela A Riddell; Jennifer S Rota; Paul A Rota
Journal:  Virol J       Date:  2005-11-22       Impact factor: 4.099

2.  In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.

Authors:  T N Figueira; L M Palermo; A S Veiga; D Huey; C A Alabi; N C Santos; J C Welsch; C Mathieu; B Horvat; S Niewiesk; A Moscona; M A R B Castanho; M Porotto
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Improving molecular tools for global surveillance of measles virus.

Authors:  Bettina Bankamp; Lauren A Byrd-Leotis; Elena N Lopareva; Gibson K S Woo; Chunyu Liu; Youngmee Jee; Hinda Ahmed; Wilina W Lim; Nalini Ramamurty; Mick N Mulders; David Featherstone; William J Bellini; Paul A Rota
Journal:  J Clin Virol       Date:  2013-06-24       Impact factor: 3.168

4.  High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice.

Authors:  Caroline I Sellin; Nathalie Davoust; Vanessa Guillaume; Dominique Baas; Marie-Françoise Belin; Robin Buckland; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Genotyping of measles virus in clinical specimens on the basis of oligonucleotide microarray hybridization patterns.

Authors:  Alexander A Neverov; Michaela A Riddell; William J Moss; Dmitriy V Volokhov; Paul A Rota; Luis E Lowe; Doris Chibo; Sheilagh B Smit; Diane E Griffin; Konstantin M Chumakov; Vladimir E Chizhikov
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

6.  Genotyping measles virus by real-time amplification refractory mutation system PCR represents a rapid approach for measles outbreak investigations.

Authors:  Diane Waku-Kouomou; Amal Alla; Bariza Blanquier; Damien Jeantet; Hayat Caidi; Ahmed Rguig; François Freymuth; Fabian T Wild
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

7.  Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression.

Authors:  Julien C Marie; Frédéric Saltel; Jean-Michel Escola; Pierre Jurdic; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  New measles genotype, Uganda.

Authors:  Apollo Muwonge; Miriam Nanyunja; Paul A Rota; Josephine Bwogi; Luis Lowe; Stephanie L Liffick; William J Bellini; Sempala Sylvester
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

9.  Molecular epidemiology of measles virus in Italy, 2002-2007.

Authors:  Fabio Magurano; Claudia Fortuna; Antonella Marchi; Eleonora Benedetti; Paola Bucci; Melissa Baggieri; Loredana Nicoletti
Journal:  Virol J       Date:  2012-11-23       Impact factor: 4.099

10.  Molecular characterization of measles viruses that circulated in Cameroon between 2010 and 2011.

Authors:  Maurice Demanou; Rajhonson Ratsitoharana; Martial Yonga; Annick Dosseh; Blanche Anya; Marie Kobela; Richard Njouom
Journal:  Virol J       Date:  2013-03-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.